Definium Therapeutics OverviewDefinium Therapeutics Net Income
Profitability analysis for DFTX.
Quarterly Net Income
-$77.10M
↓ 230.21% YoY
As of Mar 2026
Annual Net Income (TTM)
-$237.54M
↓ 206.01% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...